"Market volatility kept companies on the sidelines in the first half of 2022. Expectations for the second half of 2022 are slightly more optimistic with plenty of well-known names sitting on the sidelines as companies look for the market to find its footing and the IPO window to open."
Craig Clay, President, Donnelley Financial Solutions
Congratulations to the 8 issuers in June who made their public debut via an IPO raising over $259 million and the 9 companies who made their public debut via a SPAC merger with a total enterprise value of approximately $38 billion. Special congratulations to our clients:
- Alvotech
- Grove Collaborative
- Polestar
- Senti Biosciences
- Symbotic
- Heart Test Laboratories
